Evidence map›Paper›PMID 38432985›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Refractory Gastroesophageal Reflux Disease Successfully Treated with Endoscopic Anti-gastroesophageal Reflux Mucosal Resection by the ESD-G Method (with Video).

Shun Sasaki, Kazuhiro Ota, Taro Iwatsubo, Noriaki Sugawara, Akitoshi Hakoda, Hironori Tanaka, Yosuke Mori, Toshihisa Takeuchi, Kazuhide Higuchi, Hiroki Nishikawa

Open access · diamondAbstract readCase ReportsVideo-Audio Media
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shun SasakiSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Kazuhiro OtaSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Taro IwatsuboSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Noriaki SugawaraSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Akitoshi HakodaSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Hironori TanakaSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Yosuke MoriSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Toshihisa TakeuchiSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Kazuhide HiguchiSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Hiroki NishikawaSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Japan.
Osaka University of Pharmaceutical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 70-year-old man who had undergone treatment for gastroesophageal reflux disease (GERD) by a family doctor presented to our hospital with severe heartburn and dysphagia despite taking vonoprazan (20 mg) for 3 months. A diagnosis of vonoprazan-refractory nonerosive reflux disease was made based on esophagogastroduodenoscopy and esophageal function examinations. The patient elected to undergo endoscopic treatment for GERD. Therefore, we performed endoscopic treatment using the endoscopic submucosal dissection (ESD-G) technique developed at our institution. After endoscopic treatment, his GERD symptoms disappeared and he no longer required GERD-related medications. An examination of his esophageal function revealed the improvement of items related to GERD.

Indexed as

Endoscopic Mucosal ResectionGastroesophageal RefluxAgedHumansMalePyrrolesSulfonamidesTreatment Outcome1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanaminePyrrolesSulfonamidesendoscopic anti-gastroesophageal reflux mucosal resectionESD-Ggastroesophageal reflux disease

Identifiers

PMID38432985
PMCPMC11604385
OpenAlexW4392442975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.